🇺🇸 FDA
Patent

US 10597455

Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin

granted A61PA61P11/00A61P37/00

Quick answer

US patent 10597455 (Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin) held by The Regents of the University of California expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P11/00, A61P37/00